Can dose outside the PTV influence the risk of distant metastases in stage I lung cancer patients treated with stereotactic body radiotherapy (SBRT)?
- Resource Type
- Article
- Source
- In
Radiotherapy and Oncology September 2018 128(3):513-519 - Subject
- Language
- ISSN
- 0167-8140